DD138902A5 - Verfahren zur herstellung von 2,3-polymethylen-4-oxo-4h-pyrido-(1,2-a)-pyrimidin - Google Patents

Verfahren zur herstellung von 2,3-polymethylen-4-oxo-4h-pyrido-(1,2-a)-pyrimidin

Info

Publication number
DD138902A5
DD138902A5 DD78207372A DD20737278A DD138902A5 DD 138902 A5 DD138902 A5 DD 138902A5 DD 78207372 A DD78207372 A DD 78207372A DD 20737278 A DD20737278 A DD 20737278A DD 138902 A5 DD138902 A5 DD 138902A5
Authority
DD
German Democratic Republic
Prior art keywords
polymethylene
pyrido
pyrimidine
oxo
preparation
Prior art date
Application number
DD78207372A
Other languages
English (en)
Inventor
Istvan Hermecz
Ferenc Fueloep
Zoltan Meszaros
Gabor Bernath
Josef Knoll
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Publication of DD138902A5 publication Critical patent/DD138902A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Communicable Diseases (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DD78207372A 1977-08-19 1978-08-18 Verfahren zur herstellung von 2,3-polymethylen-4-oxo-4h-pyrido-(1,2-a)-pyrimidin DD138902A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU77CI1766A HU182009B (en) 1977-08-19 1977-08-19 Process for producing substituted pirido-square bracket-1,2-a-square bracket closed-pyrimidines, pyrrolo-square bracket-1,2-a-square bracket closed-pyrimidines

Publications (1)

Publication Number Publication Date
DD138902A5 true DD138902A5 (de) 1979-11-28

Family

ID=10994668

Family Applications (1)

Application Number Title Priority Date Filing Date
DD78207372A DD138902A5 (de) 1977-08-19 1978-08-18 Verfahren zur herstellung von 2,3-polymethylen-4-oxo-4h-pyrido-(1,2-a)-pyrimidin

Country Status (21)

Country Link
US (1) US4220771A (de)
JP (1) JPS5459299A (de)
AT (1) AT371818B (de)
BE (1) BE869833A (de)
CA (1) CA1117525A (de)
CH (1) CH638207A5 (de)
CS (1) CS240351B1 (de)
DD (1) DD138902A5 (de)
DE (1) DE2836449A1 (de)
DK (1) DK157021C (de)
ES (1) ES473182A1 (de)
FI (1) FI67547C (de)
FR (1) FR2416893A1 (de)
GB (1) GB2003870B (de)
GR (1) GR65275B (de)
HU (1) HU182009B (de)
NL (1) NL7808571A (de)
PL (1) PL116688B1 (de)
SE (1) SE436279B (de)
SU (1) SU749365A3 (de)
YU (1) YU196578A (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4348396A (en) * 1978-01-23 1982-09-07 Hoffmann-La Roche Inc. Substituted 11-oxo-11H-pyrido[2,1-b]quinazolines and method of inhibiting allergic reactions with them
US4395549A (en) * 1981-10-02 1983-07-26 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt. 6-Hydrazono-pyrido[2,1-b] quinazoline-11 ones
ES8406476A1 (es) * 1982-04-29 1984-07-01 Erba Farmitalia Procedimiento para preparar derivados cicloalifaticos condensados de pirido(1,2-a)pirimidinas sustituidas.
HU191192B (en) * 1982-11-16 1987-01-28 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt,Hu Process for producing new azepino /1,2-a/ pyrimidine derivatives of bronchodilating activity and acid additional salts thereof and pharmaceiutical compositions containing them
CZ281628B6 (cs) * 1991-07-29 1996-11-13 Warner-Lambert Company Deriváty chinazolinu a farmaceutické přípravky na jejich bázi
US5892917A (en) * 1995-09-27 1999-04-06 Microsoft Corporation System for log record and log expansion with inserted log records representing object request for specified object corresponding to cached object copies
US8772301B2 (en) * 2009-12-18 2014-07-08 Sunovion Pharmaceuticals, Inc. Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1088968B (de) * 1958-07-03 1960-09-15 Bayer Ag Verfahren zur Herstellung von mehrkernigen, heterocyclischen, einen 4-Oxo-3, 4-dihydro-pyrimidinring enthaltenden Verbindungen
US2992221A (en) * 1958-07-03 1961-07-11 Petersen Siegfried Polymethylene-oxoquinazolines and their production
US3271396A (en) * 1964-08-17 1966-09-06 Squibb & Sons Inc Pyrido-quinazoline derivatives
DE1803785A1 (de) * 1968-10-18 1970-06-04 Hoechst Ag Verfahren zur Herstellung von 1,2-disubstituierten 6-Oxo-1.4.5.6-tetrahydropyrimidinen
US3790573A (en) * 1971-11-11 1974-02-05 Smithkline Corp Imidazo and pyrimido(2,1-b)quinazolines
US3965100A (en) * 1975-02-26 1976-06-22 E. R. Squibb & Sons, Inc. 2,3-Dihydrocyclopenta[d]pyrido[1,2-a]pyrimidin-10(1H)-one and its derivatives
US4033961A (en) * 1975-10-07 1977-07-05 Warner-Lambert Company Pyrido[2-1-b]quinazolin-ones and their methods of preparation
DE2557425A1 (de) * 1975-12-19 1977-06-30 Boehringer Sohn Ingelheim Chinazolonderivate
JPH0297996A (ja) * 1988-10-05 1990-04-10 Toshiba Corp 画像データ変換回路

Also Published As

Publication number Publication date
FR2416893B1 (de) 1983-07-22
GR65275B (en) 1980-07-31
SE436279B (sv) 1984-11-26
BE869833A (fr) 1978-12-18
FI67547B (fi) 1984-12-31
JPS5459299A (en) 1979-05-12
ES473182A1 (es) 1979-04-01
CS240351B1 (en) 1986-02-13
DE2836449A1 (de) 1979-03-22
GB2003870A (en) 1979-03-21
DK157021B (da) 1989-10-30
DK367378A (da) 1979-02-20
SE7808771L (sv) 1979-02-20
FI67547C (fi) 1985-04-10
PL209131A1 (pl) 1979-06-04
CS541878A1 (en) 1985-05-15
CH638207A5 (de) 1983-09-15
US4220771A (en) 1980-09-02
FI782517A (fi) 1979-02-20
YU196578A (en) 1983-10-31
HU182009B (en) 1983-12-28
SU749365A3 (ru) 1980-07-15
GB2003870B (en) 1982-07-21
DK157021C (da) 1990-04-02
FR2416893A1 (fr) 1979-09-07
CA1117525A (en) 1982-02-02
DE2836449C2 (de) 1990-09-06
ATA597178A (de) 1982-12-15
PL116688B1 (en) 1981-06-30
AT371818B (de) 1983-08-10
NL7808571A (nl) 1979-02-21

Similar Documents

Publication Publication Date Title
DD133803A1 (de) Verfahren zur herstellung von furokumarinen
DD137225A5 (de) Verfahren zur herstellung von 1,2,4-triazin-5-on-derivaten
DD134090A5 (de) Verfahren zur herstellung von pyridinylaminoalkylaether
DD137438A5 (de) Verfahren zur herstellung von n'-phenyl-n-methylharnstoffderivaten
DE3750501D1 (de) Verfahren zur Herstellung von Pyrimidinen.
DE3750500D1 (de) Verfahren zur Herstellung von Aminopyrimidinen.
ATA392577A (de) Verfahren zur herstellung von acylcyaniden
DD138902A5 (de) Verfahren zur herstellung von 2,3-polymethylen-4-oxo-4h-pyrido-(1,2-a)-pyrimidin
DD134091A5 (de) Verfahren zur herstellung von 1,3,5-triazin-2,6-dionen
DD136832A5 (de) Verfahren zur herstellung von 1,2-dichloraethan
LU79293A1 (de) Verfahren zur herstellung von chinazolin-derivaten
DD130144A5 (de) Verfahren zur herstellung von benzoylcyanid
DD130240A5 (de) Verfahren zur herstellung von acylcyaniden
DD137097A5 (de) Verfahren zur herstellung von 2-(2',2',2'-trihalogenaethyl)-4-halogencyclobutan-1-onen
DD134100A5 (de) Verfahren zur herstellung von lactamen
DD135497A5 (de) Verfahren zur herstellung von 17 beta hydroxy-4-androsten-3-onen
AT352696B (de) Verfahren zur herstellung von cyclohexandion- (1,4)-tetramethyldiketal
ATE16800T1 (de) Verfahren zur herstellung von 2,4-diamino-(3,5dimethoxy-4-methoxy-ethoxy-benzyl)-pyrimidin.
DD134522A5 (de) Verfahren zur herstellung von 1,2,4-triazin-5-on-derivaten
LU78483A1 (de) Verfahren zur herstellung von benzoxazolyl-phenylstilbenen
DD139252A5 (de) Verfahren zur herstellung von alkylphenolen
ATA834378A (de) Verfahren zur herstellung von 2,6-pyridincarbon- saeure
LU78135A1 (de) Verfahren zur herstellung von benzodifuranen
DD135382A5 (de) Verfahren zur herstellung von triazolo-thieno-diazepin-1-onen
PT65238A (de) Verfahren zur herstellung von 2,4-diamino-5-(3',4',5'-trimethoxybenzyl)pyrimidin

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee